首页> 外文会议>ASMS Conference on Mass Spectrometry and Allied Topics >Glycosylation Profiling of IL-23: Determination of N-Glycosylation Sites and Structure Characterization of the Oligosaccharides by Mass Spectrometry
【24h】

Glycosylation Profiling of IL-23: Determination of N-Glycosylation Sites and Structure Characterization of the Oligosaccharides by Mass Spectrometry

机译:IL-23的糖基化分析:通过质谱法测定N-糖基化位点和寡糖的结构表征

获取原文

摘要

As a new member of the growing family of interleukin (IL)-12-related cytokines, IL-23 is a key immunoregulatory cytokine that coordinates innate and adaptive immune responses (1). IL-23 promotes end-stage inflammation, which makes it and the proteins in its down-stream pathway potential targets for the treatment of immune-mediated diseases. As a heterodimeric cytokine that comprises of disulfide-linked p19 and p40 subunits, IL-23 has four potential N-glycosylation sites ~(125)NKTF, ~(135)NYSG, ~(222)NYTS, and ~(303)NASI. Structural characterization of the glycoforms of IL-23 has not yet been reported. In this presentation, we describe the use of mass spectrometry (MS) to establish the glycosylation profiles of recombinant IL-23, which includes defining glycosylation sites, the degree of occupancy of each glycosylation site, and the structures of the oligosaccharides attached to each site. Single chain IL-23 (p19-peptide linker-p40) was expressed in adenovirus or baculovirus. LC/ESI-MS and MALDI MS were applied to detect the molecular weight (MW) of the purified recombinant IL-23. MS strategies involved enzymatic digestion of the glycoprotein and analysis of the resulting peptide fragments for the determination of the site specific glycosylation pattern. Specifically, identification of glycosylated peptides generated from trypsin digestion of IL-23 was accomplished by LC/ESI-MS peptide mapping followed by precursor ion scans of oxonium ions of GIcNAc~(+) (m/z 204) and Hex-GIcNAc~(+) (m/z 366) on a triple quadruple MS instrument (ABI API4000). To determine the glycosylation sites and the structures of the oligosaccharides of each site, the glycopeptides were fraction collected from the RP-HPLC separation and de-glycosylated with PNGase F. Both the glycopeptides and their corresponding apopeptides were further studied by MALDI MS (ABI DE-STR) and LC/ESI-MS/MS (Micromass Q-Tof2).
机译:作为生长的白细胞介素(IL)-12相关细胞因子的新成员,IL-23是一个关键免疫调节细胞因子,其坐标并进行生先生和适应性免疫应答(1)。 IL-23促进终末期炎症,使其和蛋白质在其下游途径潜在靶标的治疗免疫介导的疾病。作为包含二硫化二硫化物连接的P19和P40亚基的异二聚细胞因子,IL-23具有四个潜在的N-糖基化位点〜(125)NKTF,〜(135)NYS,〜(303)NASI。尚未报道IL-23的糖族的结构表征。在该介绍中,我们描述了使用质谱(MS)的使用来建立重组IL-23的糖基化谱,其包括限定糖基化位点,每个糖基化位点的占用度,以及附着在每个部位的寡糖的结构。单链IL-23(P19-肽链接器-P40)在腺病毒或杆状病毒中表达。施用LC / ESI-MS和MALDI MS检测纯化的重组IL-23的分子量(MW)。 MS策略涉及酶促消化糖蛋白的蛋白和分析所得肽片段,用于测定位点特异性糖基化图案。具体地,通过LC / ESI-MS肽映射完成从IL-23的胰蛋白酶消化产生的糖基化肽的鉴定,然后通过GICNAC〜(+)(m / z 204)和Hex-gicnac〜( +)(m / z 366)在三倍的MS仪器上(ABI API4000)。为了确定每个部位的寡糖的糖基化位点和寡糖的结构,糖肽是从RP-HPLC分离和用PNGase F的脱脂糖化物中收集的馏分。通过MALDI MS进一步研究糖肽及其相应的凋亡肽(ABI DE -str)和LC / ESI-MS / MS(Micromass Q-TOF2)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号